One-click delivery the next day e-commerce tap moved all the medical people's cake!

Text . . . Since February 2016, when the State Council ordered the cancellation of administrative approvals for third-party drug logistics business, the logistics giant's cross-border foray into the pharmaceutical sector has gained momentum.
, JD.com, Shunfeng, postal services, "three-way one-way" and other logistics giants have been down, competing for the pharmaceutical circulation market.
Fujian Province, which relies on the volume of procurement, has proposed new rules in March 2020 to encourage the implementation of the "one-vote system" and the unified settlement of payments by medical insurance agencies.
under the pressure of "one-vote system" and diluted profits, third-party pharmaceutical logistics platform is more favored by production enterprises.
August 11, the Shaanxi Drug Administration issued a public letter saying that it had agreed to apply for third-party drug logistics filing qualification by Shaanxi JD.com Pharmaceutical Supply Chain Management Co., Ltd.
With its higher efficiency, a wider coverage of the network, not only is expected to fundamentally change the pharmaceutical industry's dependence on intermediate links, but also will use this to pry the pharmaceutical logistics 400 billion market, as if to announce "this cake I want to start."
drug circulation is facing a major change.
"mountain rain want to wind full of buildings" is the real picture of the current pharmaceutical commercial companies, and the quality of drug circulation hidden dangers, grayscale interests are more worthy of attention.
, how on earth do pharmaceutical commercial companies "live" under the competition with pharmaceutical e-commerce logistics? How can the pharmaceutical circulation ecology get rid of the stubborn disease of gold sales? Naturally, it became the biggest problem.
1. It is time to put an end to the individual phenomenon of fake and inferior drug quality: because of the volume of procurement or low-cost winning bid, individual enterprises have to supply shoddy drugs, medical supplies, if some places in access, sales, use of strict management, enterprises have to avoid seeking other channels.
real name complaints: products by a large number of fake and inferior products maliciously depressed low prices.
the cost of imitation, competition and illegality is really too low.
is selling hot products, the sooner the rough, low-end cottages, enterprises have no way.
also spit slot: including well-known e-commerce, including pharmaceutical business, although for the rapid development period, but also need to pay attention to the impact of goodwill.
in the pharmaceutical field, enterprises should be glad that the chemical drug consistency evaluation and biosypolor drug technology threshold requirements are more perfect.
, the first imitation is difficult to imitate even after the listing, will still be held hostage in the irresponsible imitation chaos.
the market choice is ineffective or inefficient, doctors and patients can only identify the original research drugs and their goodwill, which is the guarantee of labeling, not the guarantee of science.
Pharma commercial as the "last kilometer" of drug supply players, even directly to consumers, once the service of the drug quality problems, shoddy situation, no doubt for pharmaceutical commercial companies (including pharmaceutical e-commerce) also means a devastating blow.
, "two-vote system" "one-vote system" also brings some problems "enterprise purchase and sale activities, the settlement method includes "one-vote system" and "two-vote system".
difference is that "one-vote settlement" is the purchase of goods to the factory price one-vote system, so that the sales party unified insulation of value-added tickets, including transportation costs.
"two-vote settlement" is the value-added ticket issued by the buyer for the purchaser for its factory price, freight is issued by the shipper alone freight invoice to the purchaser.
", the one-vote, two-vote system is not unique to the pharmaceutical sector.
and the implementation of both in the field of medicine, but also fully reflects the special characteristics of the field of medicine.
is why the one-vote, two-vote system has become an inevitable disadvantage in the field of medicine.
1. The one-vote system allows buyers to face directly a large number of buyers, for the problem of counterfeit products, identification and recovery is undoubtedly more difficult than the "two-vote system."
, but at the same time, combined with the voice of the people and the lifeblood of the times, the positive meaning of the one-vote system is irreplaceable, but also the hard task of the current reform.
the need to learn from the "secondary school for the body, Western learning for use" approach, not only to guide pharmaceutical industry enterprises to practice the one-vote system, but also to pharmaceutical distribution enterprises (including third parties) to implement a banded liability.
And at present, the industry happens to be in the two-vote system, one-vote system of exploration and transition stage, no doubt it is more necessary to establish early drug consumption production, circulation and other supply chain on the responsibility and division of labor, as far as possible from the reform measures to extract its essence, avoid traps.
use both form and function.
" June 30, Fuzhou drug inspectors held a public hearing in accordance with the law on a case of drug sales of inferior drugs in pharmacies.
In the course of the hearing, the parties put forward three main arguments, namely: (1) the parties to buy and sell melons the procedure is legal, there is no subjective intent to sell inferior drugs
in the defense, the contractor believes that the parties purchased and sold the case of melon appearance traits through the acceptance of general, conventional acceptance can be found.
, after learning of the results of the inspection report, the parties did not take such measures as suspension of sales, and continued to sell and circulate in the market.
eventually issued a huge fine: the drugstore sold 5,000 yuan and was fined 1.1 million yuan.
"2.1-vote system, two-vote system so that the marketer left the original circulation link, may need the downstream advance capital, capital and financial assistance."
from the practical needs and long-term development, this piece of the original function needs to be replaced and resolved, otherwise it may hurt the enthusiasm of the industry.
In the future, even in the era of one-vote and two-vote systems, there is still a need to strengthen the internal cooperation of the re-supply chain of enterprises, internal and external combination of supervision requirements, so that accountability can quickly find the root cause and direct cause, clear accountability.
addition, for pharmaceutical companies, joint and several liability on the drug supply chain strip appears to be an additional burden and control, but in fact it is also self-atonement and self-help.
also take this opportunity to guide pharmaceutical commercial companies to improve their management and improve their lower social image.
the emergence of shoddy and shoddy, for the pharmaceutical industry, the commercial sector, are a crisis.
, on the one hand, to encourage the establishment of industry alliances, is to exercise the responsibility of industry supervision, the establishment of a platform for incident acceptance.
, on the other hand, encourage consumers to report clues in a timely manner, backtrack from the sales side, distribution alliances and industrial alliances to monitor each other, forcing research and development production responsibilities.
Three, pharmaceutical e-commerce for the industry brought about by the changes have mixed feelings and worries" July 24, 2020, the State Health Insurance Administration issued "on the establishment of pharmaceutical prices and credit evaluation system guidance (draft for comments).
The centralized purchasing agencies in various regions shall establish and implement the system of evaluation of pharmaceutical prices and credit for recruitment on a provincial basis by the end of 2020, adhere to the principle of co-construction and sharing of common governance, promote active participation, and guide pharmaceutical enterprises to conscientiously fulfill their obligations to abide by price rules and operate in good faith.
" in terms of product quality, there is no doubt that pharmaceutical e-commerce than traditional pharmaceutical business practices more cautious.
one of the reasons is that the two face different customers, the majority of traditional medicine business focus is only need to deal with good medical institutions, administrative supervision on everything.
fouls make mistakes, and then into the focus of monitoring, but still can not change its business activities scene, many large pharmaceutical distribution enterprises have committed on the change, change again.
and large pharmaceutical industry enterprises have exposed such problems in terms of tax-related and gold-related issues.
and the cautious approach of pharmaceutical e-commerce may also be an important basis for shaking up the circulation of traditional medicine.
On the other hand, in the drug circulation, the role of pharmaceutical e-commerce similar to the "super-buyer" meaning, playing the role of financial communication, which in turn requires enterprises pharmaceutical industry enterprises to advance capital situation must also exist, and with the expansion of the layout, the situation will continue to increase, strong pharmaceutical e-commerce will therefore push up drug prices? Will channel monopoly, flow monopoly and scale monopoly be used to restrict the wide price competition in the pharmaceutical industry and the pharmaceutical commercial chain? Therefore, the traditional medicine business special supervision content, for the pharmaceutical e-commerce naturally can not be less! Fourth, to encourage pharmaceutical businesses in remote and marginal rich competition at present, cross-border logistics leading enterprises there is a common problem, that is, the distribution of drugs in remote areas has been a difficult problem, and in this regard, most small and medium-sized pharmaceutical enterprises have undoubtedly obtained a unique living space.
, the traditional medicine circulation field functions not only logistics and distribution, but also drug wholesale, distribution, and even government affairs and other functions.
the head of the Drug Administration had predicted that the reforms would eventually divide commercial companies: one is the distribution-only logistics of medicines, the other is the distribution of pharmaceutical distributors only.
and the market well-known National Pharmaceutical Holdings, Kyushua Tong and other circulation giants, often distribution business is its main source of revenue, logistics may just be the icing on the cake.
" but in any case, as far as logistics is concerned, JD.com, postal services and other large enterprises, will be a large extent to change the current domestic maintenance of many years of pattern, once the entry with its "efficient, convenient, safe" core competitiveness to establish a foothold, most traditional pharmaceutical circulation enterprises were kicked out, it is not entirely possible.
And, once the combination of pharmaceutical e-commerce and pharmaceutical logistics, "factory direct sales" "one-stop service" move is not the circulation of the field of cake, imagine the mountains, the network under the next day the next day the drug has been delivered, and "you" what? Therefore, "one-vote system" and "two-vote system" for traditional pharmaceutical commercial companies is not only a huge challenge, but also an unprecedented opportunity, will be brave responsibility, good goodwill, personality service value is the greatest, who belongs to who wins, really can not say!